Literature DB >> 24530996

Inhaled fluticasone and budesonide increased the risk of serious pneumonia in COPD.

Patrick White1.   

Abstract

Entities:  

Keywords:  Epidemiology; Respiratory Medicine (see Thoracic Medicine)

Mesh：

Substances：

Year:  2014        PMID： 24530996     DOI： 10.1136/eb-2013-101695

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  4 in total

1.  Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® Trial.

Authors:  Bartolome R Celli; Marc Decramer; Guus M Asijee; Katrin Kupas; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2015-03-27

2.  Journal Club: Inhaled Corticosteroids- Refining Our Understanding of Their Role in Maintenance Treatment for COPD.

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2017-01-05

3.  Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).

Authors:  Claus F Vogelmeier; Guus M Asijee; Katrin Kupas; Kai M Beeh
Journal:  Adv Ther       Date:  2015-06-23       Impact factor: 3.845

4.  Effects of Budesonide Combined with Noninvasive Ventilation on PCT, sTREM-1, Chest Lung Compliance, Humoral Immune Function and Quality of Life in Patients with AECOPD Complicated with Type II Respiratory Failure.

Authors:  Erxiang Gao; Chi Zhang; Jianping Wang
Journal:  Open Med (Wars)       Date:  2019-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.